Date of filling in this questionnaire or last update: 04/12/2020
1. IDENTIFICATION & BASIC DESCRIPTION
Cohort name
  COVICAT
Country
 

  • Spain

Name
  Manolis Kogevinas
Institution
  ISGlobal
Email
  manolis.kogevinas@isglobal.org
Name
  Kurt Straif
Institution
  ISGlobal
Email
  kurt.straif@isglobal.org
Name of committee
  CEIm Parc de Salut Mar
Contact Principal Investigator (name)
  Manolis Kogevinas
Data access policy (briefly describe)
  Data access upon request
Is this cohort part of a consortium? (name consortium)
  No
Participation in pooled analyses
 

  • The cohort is potentially interested in participating in pooled analyses of (European) occupational cohort studies (note pooled analyses also includes remote decentralized analyses that would not require any transfer of primary data as well as meta-analyses).

Main aim of cohort, please briefly describe the main objectives of the cohort
  COVID-19 cohort, with epidemiological information and serology for SARS-CoV-2
Study design (please select as many as appropriate)
 

  • Prospective cohort

Source population (please select as many as appropriate)
 

  • General population: National
  • General population: Regional

Inclusion criteria
  Cohort composed of previous studies: GCAT, MCC-Spain, ECRHS, Urban Training, INMA, BISC
Enrollment
  Completed
Age range at entry (main cohort)
 

Minimum Maximum Mean
15 93 55

Men at enrollment
  4139
Women at enrollment
  6363
Children (<18 years) at enrollment
  273 (INMA)
Comments
  COVICAT cohort has used existing studies to contact participants again and ask about the COVID-19 risk factors, in the context of the pandemic.
2. OUTCOME FOLLOW-UP
Type of data for outcome follow-up (please select as many as appropriate)
 

  • Active (contact with participants)
  • Hospital / physician diagnoses

Active (contact with participants) (specify)
 

  • We will follow-up the cohort by phone/app/online questionnaires and invite them to participate to the serology test

Hospital / Physician diagnoses (specify)
 

  • Data Analysis Program for Health Research and Innovation (PADRIS) for the GCAT cohort

First follow-up period (provide year)
  2021
Last follow-up period (provide year)
  2022
Number of follow-ups after baseline (provide number)
  0
3. OCCUPATIONAL EXPOSURES
Source of exposure data collected (please select as many as appropriate)
 

  • Questionnaire, Personal (Self-reporting or interview)
  • Other (specify)

Specify: Other
  blood samples
Occupational history/time frame
  Other (specify)
Specify: Other
  at enrollment in the original cohort, at enrollment in the COVICAT study, during the lockdown (March-May 2020)
Occupational coding performed
  Yes
Occupation (specify coding system used)
 

  • CNO-11

Methods for exposure assessment (please select as many as appropriate)
 

  • GIS (other spatial methods)
  • Expert assessment
  • Measurements (external sampling, biomarkers)
  • Self-report

4. OUTCOMES EVALUATED
Baseline - type of outcome data collected (select more than one if applicable)
 

  • Biomarker (specify)

Specify: Biomarker
  SARS-CoV-2 antibodies (IgM, IgA, IgG)
Outcome type (please select as many as appropriate)
 

  • Morbidity

5. BIOLOGICAL SAMPLES & ANALYSIS
Biological samples collected
 

  • Blood

Genetic and other lab analyses
 

  • Other (specify)

Specify: Other
  SARS-CoV-2 antibodies (IgM, IgG, IgA)
6. Other Information
 

  • Alcohol
  • Anthropometry
  • Demographics
  • Education
  • Environmental, air pollution
  • Environmental other (specify)
  • Medical history
  • Personality
  • Physical exercise
  • Residential history
  • Socioeconomic status
  • Smoking
  • Other (specify)

Specify: Environmental other
  Green spaces, noise
Specify: Other
  COVID-19 symptoms and contacts, social support questionnaire
Possibility for linkage to data registries/data enrichment via data linkage
 

  • Other (specify)

Specify: Other
  PADRIS
Please describe plans that are funded or most likely to be funded
  We have only done the baseline, follow-up is planned for beginning 2021